Patent US5173490A successfully refreshed from Google Patents.
US5173490A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Benzisoxazole and benzisothiazole compounds
Assignee: Institut Servier de Medecine Translationnelle SARL
•
Filing: 1992-01-07
•
Granted: 1992-12-22
•
Expires: 2012-01-07
Abstract
Abstract The compounds are N-substituted N'-(benzisoxazolyl or benzisothiazolyl) piperazines useful as sedative, anxiolytic, anti-aggressive and analgesic agents and for the treatment of schizophrenia and depression. A compound disclosed is (R,S)-3-{1-[(benzocyclobutan-1-yl)methyl]piperazin-4-yl}-6-fluoro-1,2- benzisoxazole.
Inventors
- 👤 Jean-Louis Peglion
- 👤 Joel Vian
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-11-09 08:53
CPC Classifications
C; C07; C07D; C07D275/00; C07D275/04; A; A61; A61P; A61P25/00; A61P25/04; A61P25/18; A61P25/20; A61P25/24; A61P25/26; C07D261/00; C07D261/20
Claims Analysis
Total Claims: 14
Claim 1
Independent Claim
161 words
A compound selected from the group consisting of: benzisoxazole and benzisothiazole compounds of formula I: ##STR10## in which: X 1 , X 2 , X 3 , X 4 and X 5 : which are the same or different, each represent: hydrogen, halogen, alkyl, alkoxy, or alkylthio in each of which the alkyl moiety is straight-chained or branched and contains 1 to 5 carbon atoms, inclusive, hydroxy, carboxylic acid, acyloxy, trifluoromethyl, nitro, amino, or acetamido, or two of them in adjacent positions together form methylenedioxy, ethylenedioxy, or vinylenedioxy; R 1 represents hydrogen or straight-chained or branched alkyl containing 1 to 5 carbon atoms, inclusive; m and n each represent 0, 1, 2, or 3, provided that m+n≧1; p represents 0 or an integer of 1 to 6 inclusive; q represents 2 or 3; and Y represents oxygen or S(O) z in which z is 0, 1, or 2; in racemic and optically active forms, and the physiologically-tolerable acid addition salts thereof.
Claim 2
Dependent Claim
161 words
A compound selected from the group consisting of: benzisoxazole and benzisothiazole compounds of formula I: ##STR10## in which: X 1 , X 2 , X 3 , X 4 and X 5 : which are the same or different, each represent: hydrogen, halogen, alkyl, alkoxy, or alkylthio in each of which the alkyl moiety is straight-chained or branched and contains 1 to 5 carbon atoms, inclusive, hydroxy, carboxylic acid, acyloxy, trifluoromethyl, nitro, amino, or acetamido, or two of them in adjacent positions together form methylenedioxy, ethylenedioxy, or vinylenedioxy; R 1 represents hydrogen or straight-chained or branched alkyl containing 1 to 5 carbon atoms, inclusive; m and n each represent 0, 1, 2, or 3, provided that m+n≧1; p represents 0 or an integer of 1 to 6 inclusive; q represents 2 or 3; and Y represents oxygen or S(O) z in which z is 0, 1, or 2; in racemic and optically active forms, and the physiologically-tolerable acid addition salts thereof.
Claim 3
Dependent Claim
17 words
A compound of claim 1 which is selected from: (R,S)-3-{1-[(benzocyclobutan-1-yl)methyl]piperazin-4-yl}-6-fluoro-1,2-benzisoxazole and the physiologically-tolerable acid addition salts thereof.
Claim 4
Dependent Claim
13 words
A compound of claim 1 which is selected from: (R,S)-3-{1-[(benzocyclobutan-1-yl)methyl]piperazin-4-yl}-6-fluoro-1,2-benzisoxazole and its hydrochloride.
Claim 5
Dependent Claim
13 words
A compound of claim 1 which is selected from: (R,S)-3-{1-[4-(benzocyclobutan-1-yl)butyl]piperazin-1-yl}-1,2-benzisothiazole and its hydrochloride.
Claim 6
Dependent Claim
13 words
A compound of claim 1 which is selected from: (R,S)-3-{1-[(benzocyclobutan-1-yl)methyl]piperazin-4-yl}-1,2-benzisoxazole and its hydrochloride.
Claim 7
Dependent Claim
13 words
A compound of claim 1 which is selected from: 3-[1-(indan-2-yl)piperazin-4-yl]-6-fluoro-1,2-benzisoxazole and its fumarate.
Claim 8
Dependent Claim
13 words
A compound of claim 1 which is selected from: (R,S)-3-{1-[3-(benzocyclobutan-1-yl)propyl]piperazin-4-yl}-1,2-benzisothiazole and its hydrochloride.
Claim 9
Dependent Claim
8 words
A compound of claim 1 which is: 3-{1-[(5,6-dimethoxyindan-2-yl)methyl]piperazin-4-yl}-1,2-benzisothiazole.
Claim 10
Dependent Claim
8 words
A compound of claim 1 which is: (R,S)-3-{1-[(4,5-dimethoxybenzocyclobutan-1-yl)-methyl]piperazin-4-yl}-6-fluoro-1,2-benzisoxazole.
Claim 11
Dependent Claim
8 words
A compound of claim 1 which is: (R,S)-3-{1-[(4,5-dimethoxybenzocyclobutan-1-yl)-methyl]piperazin-4-yl}-1,2-benzisoxazole.
Claim 12
Dependent Claim
29 words
A pharmaceutical composition useful to treat psychosis and anxiety containing as active ingredient an effective amount of a compound of claim 1 together, with one or more pharmaceutically-acceptable excipients.
Claim 13
Dependent Claim
41 words
A method for treating a living animal afflicted with anxiety and psychosis, or comprising the step of administering to the said living animal an amount of a compound of claim 1 which is effective for the alleviation of the said condition.
Claim 14
Dependent Claim
48 words
As a intermediate, an amide compound of formula V: ##STR11## in which: X 1 , X 2 , X 3 , X 4 , X 5 , R 1 , m, n, p', q and Y have the meanings defined in claim 1 and p' is 1-6 inclusive.
References Cited (Backward Citations)
US3822267A
Cited
US4104387A
Cited
US4104388A
Cited
US4260610A
Cited
US4352811A
Cited
US4355037A
Cited
US4452799A
Cited
US4544663A
Cited
GB2163432A
Cited
EP0196132A2
Cited
US4812461A
Cited
EP0281309B1
Cited
EP0314098A2
Cited
EP0329168A2
Cited
EP0353821A2
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1995-12-22 | 1996-06-22 | 1996-12-22 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1999-12-22 | 2000-06-22 | 2000-12-22 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 2003-12-22 | 2004-06-22 | 2004-12-22 | $7700.00 | Window Closed / Lapsed |